Effects of FW2 Nanoparticles Toxicity in a New In Vitro Pulmonary Vascular Cells Model Mimicking Endothelial Dysfunction.
J DeweirdtT DucretJ-F QuignardV Freund-MichelS LacommeE GontierB MullerR MarthanC GuibertIsabelle BaudrimontPublished in: Cardiovascular toxicology (2021)
Several epidemiological studies have revealed the involvement of nanoparticles (NPs) in respiratory and cardiovascular mortality. In this work, the focus will be on the effect of manufactured carbon black NPs for risk assessment of consumers and workers, as human exposure is likely to increase. Since the pulmonary circulation could be one of the primary targets of inhaled NPs, patients suffering from pulmonary hypertension (PH) could be a population at risk. To compare the toxic effect of carbon black NPs in the pulmonary circulation under physiologic and pathological conditions, we developed a new in vitro model mimicking the endothelial dysfunction and vascular dynamics observed in vascular pathology such as PH. Human pulmonary artery endothelial cells were cultured under physiological conditions (static and normoxia 21% O2) or under pathological conditions (20% cycle stretch and hypoxia 1% O2). Then, cells were treated for 4 or 6 h with carbon black FW2 NPs from 5 to 10 µg/cm2. Different endpoints were studied: (i) NPs internalization by transmission electronic microscopy; (ii) oxidative stress by CM-H2DCFDA probe and electron paramagnetic resonance; (iii) NO (nitrites and nitrates) production by Griess reaction; (iv) inflammation by ELISA assay; and (v) calcium signaling by confocal microscopy. The present study characterizes the in vitro model mimicking endothelial dysfunction in PH and indicates that, under such pathological conditions, oxidative stress and inflammation are increased along with calcium signaling alterations, as compared to the physiological conditions. Human exposure to carbon black NPs could produce greater deleterious effects in vulnerable patients suffering from cardiovascular diseases.
Keyphrases
- endothelial cells
- pulmonary hypertension
- oxidative stress
- pulmonary artery
- induced apoptosis
- end stage renal disease
- risk assessment
- newly diagnosed
- oxide nanoparticles
- ejection fraction
- pulmonary arterial hypertension
- chronic kidney disease
- high glucose
- coronary artery
- cardiovascular disease
- induced pluripotent stem cells
- pluripotent stem cells
- peritoneal dialysis
- type diabetes
- diabetic rats
- high resolution
- mass spectrometry
- heat stress
- quantum dots
- cardiovascular events
- high speed